BioElectronics Corporation (BIEL)
OTCMKTS
· Delayed Price · Currency is USD
0.0002
0.00 (0.00%)
Apr 24, 2025, 3:50 PM EDT
BioElectronics Statistics
Total Valuation
BioElectronics has a market cap or net worth of 7.41 million.
Market Cap | 7.41M |
Enterprise Value | n/a |
Important Dates
Earnings Date | n/a |
Ex-Dividend Date | n/a |
Share Statistics
BioElectronics has 24.71 billion shares outstanding.
Current Share Class | n/a |
Shares Outstanding | 24.71B |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | +1.61% |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | 0.00% |
Float | n/a |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 4.60 |
PB Ratio | -0.49 |
P/TBV Ratio | n/a |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.01
Current Ratio | 0.01 |
Quick Ratio | 0.01 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -0.44 |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | -33.67% |
Return on Invested Capital (ROIC) | n/a |
Return on Capital Employed (ROCE) | 2.35% |
Revenue Per Employee | 178,829 |
Profits Per Employee | -32,202 |
Employee Count | 9 |
Asset Turnover | 6.32 |
Inventory Turnover | 9.20 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
Beta (5Y) | 1.37 |
52-Week Price Change | n/a |
50-Day Moving Average | 0.00 |
200-Day Moving Average | 0.00 |
Relative Strength Index (RSI) | 57.41 |
Average Volume (20 Days) | 10,927,977 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | 0.06 |
Income Statement
In the last 12 months, BioElectronics had revenue of 1.61 million and -289,821 in losses. Loss per share was -0.00.
Revenue | 1.61M |
Gross Profit | 795,532 |
Operating Income | -137,134 |
Pretax Income | -289,821 |
Net Income | -289,821 |
EBITDA | n/a |
EBIT | -137,134 |
Loss Per Share | -0.00 |
Balance Sheet
The company has 925 in cash and 13.34 million in debt, giving a net cash position of -13.34 million or -0.00 per share.
Cash & Cash Equivalents | 925 |
Total Debt | 13.34M |
Net Cash | -13.34M |
Net Cash Per Share | -0.00 |
Equity (Book Value) | -15.12M |
Book Value Per Share | -0.00 |
Working Capital | -5.85M |
Cash Flow
Operating Cash Flow | -320,299 |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Margins
Gross margin is 49.43%, with operating and profit margins of -8.52% and -18.01%.
Gross Margin | 49.43% |
Operating Margin | -8.52% |
Pretax Margin | -18.01% |
Profit Margin | -18.01% |
EBITDA Margin | n/a |
EBIT Margin | -8.52% |
FCF Margin | n/a |
Dividends & Yields
BioElectronics does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -3.11% |
Shareholder Yield | -3.11% |
Earnings Yield | -3.91% |
FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
BioElectronics has an Altman Z-Score of -706.67. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | -706.67 |
Piotroski F-Score | n/a |